CytoSorbents Corporation announced the launch of its newly redesigned and consolidated website at www.cytosorbents.com. The theme of “Working to Save Lives Together” highlights two decades of successful collaboration with the international medical and research communities to continuously refine how our therapies, such as CytoSorb, ECOS-300CY, and VetResQ are being used to help patients survive life-threatening illnesses. The new website, built from the ground up, unifies our corporate and product information into a single, cohesive and comprehensive information hub for healthcare professionals, investors, and other key stakeholders. Visitors will find a streamlined modern design, intuitive navigation, and extensive content on our company, technology, therapies, pipeline that includes DrugSorb-ATR and HemoDefend-BGA clinical studies, investor conferences, and much more.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSO:
- CTSO Upcoming Earnings Report: What to Expect?
- CytoSorbents files $150M mixed securities shelf
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
- CytoSorbents to present at inaugural AAPI World Health Congress
- CytoSorbents secures $20M credit facility